Select your language
16.04.2025
From 31.3-12.4.2025 the 14-day course “Interdisciplinary training in genomic epidemiology and public health bioinformatics (5th Edition TB)” took place at the Research Center Borstel, Leibniz Lung Center.
14.04.2025
Johanna Eggeling, a doctoral student in the Clinical Infectious Diseases group at the Research Center Borstel, has received the award for the best medical case report at the 2025 annual conference of the German Society of Pneumology (DGP) in Leipzig. The award is given in recognition of an outstanding individual case presentation in the journal Pneumologie that combines medical findin
03.04.2025
A molecular stool test, previously used primarily in children, is showing promising results for the diagnosis of tuberculosis in HIV-positive adults. This is the key finding of the international stool4TB study, conducted in Mozambique, Uganda, and Eswatini, with participation from the Research Center Borstel.
Prof. Dr. Ulrich E. Schaible, CEO
Prof. Dr. Thomas Gutsmann, Deputy Director 'Infections'
Prof. Dr. Holger Heine, Deputy Director 'Chronic Lung Diseases'
PD Dr. Barbara Kalsdorf, Deputy Medical Director
Prof. Dr. Susanne Krauss-Etschmann, Program Director 'Chronic Lung Diseases'
Prof. Dr. med. Dr. h.c. Christoph Lange, Medical Director
Prof. Dr. Stefan Niemann, Program Director 'Infections'
Prof. Dr. Frank Petersen, Representative / Infrastructures
Jürgen Repp, Head Administration
State Secretary
Guido Wendt
Ministry of Education, Science and Cultur
(Chair)
Ines Perea
Federal Ministry of Health
(Vice Chair)
Dr. Martin Oldenburg
Ministry of Justice and Health, Schleswig-Holstein
Dr. David Herr
Federal Ministry of Health
District Administrator Jan Peter Schröder
District Segeberg
Dr. Nicole Elleuche
European XFEL GmbH, Schenefeld
Dr. Katja Barth
Christian-Albrechts-Universität, Kiel
Permanent Guest:
Friederike Krüger-Bretsch
Ministry of Finances, Schleswig-Holstein
Prof. Dr. Petra Arck
Laboratory of Experimental Feto-Maternal Medicine
University Medical Center Hamburg-Eppendorf (UKE)
(Chair)
Prof. Dr. Jon Genuneit
Department of Pediatrics
University of Leipzig Medical Center
(Vice Chair)
Prof. Dr. Barbara Bröker
Institute of Immunology
University of Greifswald
Prof. Dr. Martin Peter Grobusch
Amsterdam Institute for Infection and Immunity
University of Amsterdam UMC
Prof. Dr. Regina Scherließ
Pharmaceutics and Biopharmaceutics
Kiel University
Prof. Dr. Christian Taube
Klinik für Pneumologie
Ruhrlandklinik, Universitätsmedizin Essen
Prof. Dr. Malte Spielmann
Institute of Human Genetics
University of Luebeck
In order to achieve its research goals, the Center is organized into two priority research areas - Chronic Lung Diseases and Infections - which are completed and linked by the infrastructure area Medicine. These priority research areas, which are committed to the research concept, form the lines of action to which the research groups, junior research groups and university liaison groups are assigned.
Directors and their permanent representatives are responsible for the scientific and strategic development of the priority research area and thus for the implementation of the research concept.
The medical infrastructures are managed by a Medical Director.
The CEO represents the FZB internally and externally.
The Priority Research Area Chronic Lung Diseases focuses on the pathogenetically and clinically relevant aspects of initiation and exacerbation of allergic and asthmatic diseases. On the one hand, the focus is on the analysis of the conditions that are important for the imprinting and manifestation of asthmatic reactions (from epigenetics, environmental microbiome-lung epithelial interaction to the regulation of inflammatory reactions), on the other hand, the identification of biomarker signatures for individualized diagnostics and therapy support in asthma, copd and allergies.
The Priority Research Area Infections focuses on mechanisms of virulence, persistence, antibiotic resistance, host-pathogen interaction and pathogenesis predominantly in Mycobacterium tuberculosis and develops the basis for a faster and more precise surveillance and diagnosis of mycobacterial diseases, develops new anti-infective concepts and implements an individualized treatment of M/XDR-TB.
The FZB is the lung research center of the Leibniz Association and is therefore committed to the motto “theoria cum praxi”.
The FZB sees its scientific and socio-political task in basic, disease- and patient-oriented lung research and training in this field. The field of research includes chronic inflammatory diseases of the lung of infectious and non-infectious environmental and behavioral origin. Research focuses on tuberculosis, infections with non-tuberculous mycobacteria and other bacterial and antibiotic-resistant pathogens, as well as asthma, COPD, smoking, allergens and other air pollutants.
To this end, the FZB follows an interdisciplinary research approach with the aim of addressing and answering the major questions about the causes and mechanisms of acute and chronic inflammatory diseases of the lung in such a way as to improve prevention, diagnosis, monitoring and therapy. Research into lung diseases is becoming increasingly important in an international context, also with regard to climate change. For this reason, the FZB is not only involved in research projects, but also in capacity building, laboratory support, the implementation of new technologies and clinical translation, especially in countries with high incidence of tuberculosis. The National Reference Center for Mycobacteria, appointed by the Federal Ministry of Health and the Robert Koch Institute, is based at the FZB and is also active internationally as a supranational reference center of the WHO.
The Leibniz Lung Centre in keywords:
10. Mai 2025
Borstel
25.-27. June 2025Borstel